Partnerships
Stilla Technologies
Stilla Technologies is the digital PCR company transforming complex genomic data into actionable insights across a wide range of research and clinical applications including cancer and liquid biopsy studies, cell and gene therapies, infectious disease detection, and food and environmental testing. Stilla’s groundbreaking solutions, include the industry’s first digital PCR systems to feature three, six, and seven fluorescent channels, providing biomedical researchers and clinicians the highest multiplexing and detection capacity available on the market. Stilla has U.S. headquarters in Boston, MA, European headquarters in Paris, France, and strategic distribution and business partnerships in China and throughout EMEA.

Niba Labs and Stilla Technologies began their partnership with the commitment to rapidly advance the Cell and Gene Therapy field. The ongoing collaboration is based on the co-development of innovative multiplex digital PCR assays for various applications, such as vector genome titering, sequence integrity determination, as well as detection and quantification of process-related impurities in AAV and LV products. Our recently launched Kanamycin Resistance Gene Detection 4-plex assay enables accurate high-resolution integrity and titer evaluation of residual KanR gene levels in viral vector samples from all stages of the production process.
QIAGEN
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life.

Sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows.

QIAGEN serves more than 500,000 customers worldwide in Molecular Diagnostics (human or clinical healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics).